Last reviewed · How we verify
NCT05054504: FAB-IQ
Feasibility and Acceptability of Butterfly iQ
NA trial testing Butterfly iQ in Pregnancy Related in 1,575 participants. Completed in 15 March 2024.
15 March 2024
Quick facts
| Lead sponsor | Jhpiego |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 1,575 |
| Start date | 6 October 2021 |
| Primary completion | 15 March 2024 |
| Estimated completion | 15 March 2024 |
| Sites | 1 location across Malawi |
Drugs / interventions tested
- Butterfly iQ
Conditions studied
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
Jhpiego — full company profile →
Who can join
18 and older, any sex, with Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate feasibility and acceptability of a novel intervention to integrate Butterfly IQ into antenatal care (ANC) service delivery in Malawi. The study will also explore potential impact of the intervention on selected service delivery outcomes and identification of abnormal pregnancies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05054504
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Butterfly iQ
Trials testing the same drug.
- NCT04591158 — COVID-19 and Lung Ultrasound Utility · NA · completed
Other recruiting trials for Pregnancy Related
Currently open trials in the same condition.
- NCT05909761 — Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregn · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
- NCT07518550 — Maternal and Fetal Electrocardiograms Separation Algorithm · NA · recruiting
- NCT06965530 — Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy · NA · recruiting
Other Jhpiego trials
Trials by the same sponsor.
- NCT06258200 — The Role of Gender Transformative Interventions to Strengthen Gender Equity and Improve Immunization Outcomes · NA · active not recruiting
- NCT05774626 — Injectable Contraception Cohort Study in Punjab, Pakistan · completed
- NCT05563974 — Family Led Postnatal Care in Ethiopia · NA · completed
- NCT05565196 — Birth Companion Intervention in Ethiopia, Kenya and Nigeria · NA · completed
- NCT05133661 — SUCCESS - Feasibility of HPV Testing and Treatment of Pre-cancerous Cervical Cancer Lesions (HPV Study) · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05054504 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jhpiego
- Last refreshed: 9 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05054504.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing